PROFILE

YOKOMIZO Takehiko, M.D., Ph.D.


Department of Molecular and Cellular Biochemistry

Short Biography

1988
M.D. The University of Tokyo Faculty of Medicine
1995
Ph.D. The University of Tokyo Graduate School of Medicine
1995-1998
Postdoctoral Fellow (JSPS Fellow), The University of Tokyo
1998
Research Associate, The University of Tokyo
2000
Associate Professor, The University of Tokyo
2006
Professor, Kyushu University
2012
Professor, Department of Molecular and Cellular Biochemistry, Juntendo University Faculty of Medicine
2018
Program Officer, AMED
 

Main Research Topics and Interests

  • Lipid mediators (Leukotriene, Prostaglandin)
  • Omega-3 fatty acids
  • G-protein coupled receptor
  • Knockout mice
  • Mass spectrometry

Publications (in English)

  • Original Articles (123)
  • Review Articles (25)
  • Books (28)
  • Total Citations (12,363)
  • Average Citations (83.5)

Recent Main Publications

  • Hirakata T., Matsuda A., Yokomizo T. Leukotriene B4 receptors as therapeutic targets for ophthalmic diseases. Biochim Biophys Acta Mol Cell Biol Lipids 1865, 158756 (2020)
  • Yokomizo T., M. Nakamura, T. Shimizu. Leukotriene receptors as potential therapeutic targets. J. Clin. Invest. 128, 2691-2701 (2018)
  • Hirakata T., H.C. Lee, M. Ohba, K. Saeki, T. Okuno, A. Murakami, A. Matsuda, T. Yokomizo.  Dietary omega-3 fatty acids alter the lipid mediator profile and alleviate allergic conjunctivitis without modulating Th2 immune responses. FASEB J. 33, 3392-3403 (2019)
  • Sasaki F., T. Koga, M. Ohba, K. Saeki, T. Okuno, K. Ishikawa, T. Nakama, S. Nakao, S. Yoshida, T. Ishibashi, H. Ahmadieh, M.R. Kanavi, A. Hafezi-Moghadam, J.M. Penninger, K.H. Sonoda, T. Yokomizo.  Leukotriene B4 promotes neovascularization and macrophage recruitment in murine wet-type AMD models. JCI Insight 3, 96902 (2018)
  • More

Other Specific Comments

  • Prof. Yokomizo is famous for his cloning of leukotriene B4 receptors (Nature 1997 and JEM 2000). He is a leader of lipid research in Japan, and mainly working on GPCRs on lipid mediators using biochemistry, immunology and gene targeting. English-speaking ability is required.

Link